Mo Huang

Mo Huang is currently an Associate Director in Biostatistics at Pfizer, focusing on late oncology clinical trials with an emphasis on thoracic malignancies. Previously, they held roles such as Associate Principal Scientist at Merck, where they supported early oncology clinical trials, and both a Senior Scientist and a PhD Biostatistics Intern at Genentech, where they developed analytical tools and methods. Mo conducted undergraduate research at The Genome Institute at Washington University, studying genome-wide mutation rates in cancer, and earned their Ph.D. in Statistics from The Wharton School, where they contributed to advancements in single cell RNA sequencing and deep learning applications in biological data. Mo completed a Bachelor's Degree from Washington University in St. Louis.